Surviving Cancer: Two Future Doctors Take their Battle Out of the Treatment Room and Into the Lab

by Adam Paris, ALSF

John Szigety was diagnosed at age 10 with Hodgkin lymphoma and underwent treatment at Memorial Sloan Kettering Hospital and Hackensack University Medical Center. After eight months of treatment, he suffered a relapse in early 2006, but completed treatment that June. Today, he is 11 years cancer-free. 

Researcher Profile: Studying Childhood Cancer and Adolescence

In addition to the medical research ALSF funds, ALSF also supports and funds research projects investigating quality of life issues. High quality care is a powerful tool against childhood cancer. The Quality of Life and Care grants empower those best positioned to make effective discoveries: the caregivers themselves. In our Nursing Grant awards, our grantees include nurse practitioners who are leading the field in pediatric oncology nursing practice, as well as those who will become future leaders.

Meet Childhood Cancer Hero Zach

When he was just five, Zach was diagnosed with a form of lymphoma that was very hard to treat. He relapsed, an unfortunate reality for many kids battling cancer. Zach was slipping away. But ALSF-funded research had helped to make possible a clinical trial for a new drug, crizotinib, that targeted and turned off a specific gene that fueled Zach's cancer.  Days after taking the drug, Zach was feeling better and his cancer was disappearing. Zach's uplifting story is a reminder that the research we fund can make all the difference in a child's life.


Five Things You Need to Know About Childhood Cancer Research

In October, Alex's Lemonade Stand Foundation hosted its third annual Young Investigators Summit, generously sponsored by Northwestern Mutual.  Nearly 50 young scientists who have received ALSF grants attended, shared research, networked and collaborated. This two-day summit is one of the ways ALSF helps spur advances toward cures. These young scientists each presented their research, heard presentations from established researchers and were inspired by the story of a childhood cancer hero.